Pfizer to Exit GSK's Consumer Health Arm After London Listing

KONTAN.CO.ID - LONDON. Pfizer plans to exit its 32% stake in Haleon, a consumer health joint venture with British drugmaker GSK, after the business lists as an independent company in July. GSK said on Wednesday.
GSK is spinning off Haleon, which makes Sensodyne toothpaste and Advil painkillers, so it can focus on disease prevention and treatment. GSK rejected a 50 billion pound (US$ 63 billion) offer for Haleon last year, saying it undervalued the firm.
Ini Artikel Spesial
Agar bisa lanjut membaca sampai tuntas artikel ini, pastikan Anda sudah berlangganan.
Sudah berlangganan? MasukBerlangganan dengan Google
Gratis uji coba 7 hari pertama. Anda dapat menggunakan akun Google sebagai metode pembayaran.
Kontan Digital Premium Access
Business Insight, Epaper Harian + Tabloid, Arsip Epaper 30 Hari
Rp 120.000
Business Insight
Hanya dengan 20rb/bulan Anda bisa mendapatkan berita serta analisis ekonomi bisnis dan investasi pilihan